ANTI CYSTICERCOSIS ANTIBODY

This study, conducted over 14 months, aimed to assess the effectiveness of using saliva for neurocysticercosis (NCC) diagnosis by detecting anti-cysticercus IgG antibodies. Blood and saliva samples from 40 suspected NCC patients were analyzed using ELISA. The results showed that anti-cysticercus IgG was present in the serum of 34 patients and in the saliva of 30 patients. Saliva demonstrated 88.24% sensitivity, 100% specificity, and a positive predictive value of 100%. Serum C-reactive protein (CRP) levels were also measured and showed a significant association with positive salivary anti-cysticercus IgG. The findings suggest that saliva, being a noninvasive alternative, holds promise for NCC diagnosis.